Es gab 50 kürzliche Insider-Transaktionen für Hoth Therapeutics, Inc. (HOTH), darunter 41 Käufe und 3 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.02M und die gesamten Insider-Verkäufe auf $876K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Knie Robb, Camarra Christopher Michael, Springer Graig. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — HOTH
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-08-28 |
Knie Robb |
CEO and President |
RSU-Steuereinbehalt |
310,744 |
$1.21 |
$376K |
547,387 |
| 2025-08-27 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
800,000 |
- |
- |
858,131 |
| 2025-05-08 |
Camarra Christopher Michael |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-01-14 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
7,000 |
$1.55 |
$10.85K |
7,000 |
| 2025-01-14 |
Springer Graig |
Director |
RSU-Zuteilung |
70,000 |
$1.55 |
$108.5K |
70,000 |
| 2024-08-19 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
325,000 |
$0.75 |
$245.31K |
325,000 |
| 2024-08-19 |
Sarnoff David |
Director |
RSU-Zuteilung |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-19 |
Springer Graig |
Director |
RSU-Zuteilung |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-19 |
Linsley Wayne |
Director |
RSU-Zuteilung |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-19 |
Pavell Jeff |
Director |
RSU-Zuteilung |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-16 |
Knie Robb |
CEO and President |
Informierter Kauf |
25,000 |
$0.67 |
$16.75K |
58,131 |
| 2024-01-05 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
225,000 |
$1.36 |
$306K |
225,000 |
| 2024-01-05 |
Sarnoff David |
Director |
RSU-Zuteilung |
25,000 |
$1.36 |
$34K |
25,000 |
| 2024-01-05 |
Springer Graig |
Director |
RSU-Zuteilung |
25,000 |
$1.36 |
$34K |
25,000 |
| 2024-01-05 |
Linsley Wayne |
Director |
RSU-Zuteilung |
25,000 |
$1.36 |
$34K |
25,000 |
| 2024-01-05 |
Pavell Jeff |
Director |
RSU-Zuteilung |
25,000 |
$1.36 |
$34K |
25,000 |
| 2023-07-17 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
40,000 |
$2.59 |
$103.6K |
40,000 |
| 2023-07-17 |
Sarnoff David |
Director |
RSU-Zuteilung |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2023-07-17 |
Springer Graig |
Director |
RSU-Zuteilung |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2023-07-17 |
Linsley Wayne |
Director |
RSU-Zuteilung |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2023-07-17 |
Pavell Jeff |
Director |
RSU-Zuteilung |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2022-12-13 |
Pavell Jeff |
Director |
RSU-Zuteilung |
5,075 |
- |
- |
5,075 |
| 2022-12-07 |
Pavell Jeff |
Director |
Unbekannt |
- |
- |
- |
- |
| 2022-09-19 |
Knie Robb |
CEO and President |
Informierter Kauf |
10,000 |
$0.39 |
$3.9K |
828,259 |
| 2022-09-16 |
Knie Robb |
CEO and President |
Informierter Kauf |
10,000 |
$0.40 |
$4K |
818,259 |
| 2022-03-16 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
500,000 |
$0.59 |
$295.5K |
500,000 |
| 2022-03-16 |
Sarnoff David |
Director |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-03-16 |
Springer Graig |
Director |
RSU-Zuteilung |
250,000 |
- |
- |
250,000 |
| 2022-03-16 |
Linsley Wayne |
Director |
RSU-Zuteilung |
40,000 |
- |
- |
40,000 |
| 2022-03-16 |
Johns Stefanie |
Chief Scientific Officer |
RSU-Zuteilung |
250,000 |
$0.59 |
$147.75K |
250,000 |
| 2021-01-29 |
Mats Vadim |
Director |
RSU-Zuteilung |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
225,000 |
$2.11 |
$474.75K |
225,000 |
| 2021-01-29 |
Sarnoff David |
Director |
RSU-Zuteilung |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Springer Graig |
Director |
RSU-Zuteilung |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Linsley Wayne |
Director |
RSU-Zuteilung |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Johns Stefanie |
Chief Scientific Officer |
RSU-Zuteilung |
125,000 |
$2.11 |
$263.75K |
125,000 |
| 2020-12-31 |
Knie Robb |
CEO and President |
Unbekannt |
- |
- |
- |
- |
| 2020-12-31 |
Aikido Pharma Inc. |
10 Percent Owner |
Unbekannt |
- |
- |
- |
- |
| 2020-09-08 |
Johns Stefanie |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2020-07-21 |
Rice Kenneth L Jr |
Director |
RSU-Zuteilung |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Mats Vadim |
Director |
RSU-Zuteilung |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Knie Robb |
CEO and President |
RSU-Zuteilung |
80,000 |
$3.05 |
$244K |
80,000 |
| 2020-07-21 |
Sarnoff David |
Director |
RSU-Zuteilung |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Springer Graig |
Director |
RSU-Zuteilung |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Linsley Wayne |
Director |
RSU-Zuteilung |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-05-26 |
Hayes Anthony |
Officer |
Informierter Verkauf |
- |
- |
- |
- |
| 2020-05-26 |
Hayes Anthony |
10 Percent Owner |
Informierter Verkauf |
400,000 |
$1.25 |
$500K |
1,130,674 |
| 2020-04-15 |
Springer Graig |
Director |
RSU-Zuteilung |
3,333 |
- |
- |
3,333 |
| 2020-04-15 |
Linsley Wayne |
Director |
Unbekannt |
- |
- |
- |
- |
| 2020-04-15 |
Linsley Wayne |
Director |
RSU-Zuteilung |
3,333 |
- |
- |
3,333 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
